EIM
Essex Investment Management’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-431,848
| Closed | -$2.68M | – | 431 |
|
|
2022
Q1 | $2.68M | Buy |
431,848
+19,973
| +5% | +$124K | 0.33% | 89 |
|
|
2021
Q4 | $2.9M | Buy |
411,875
+31,139
| +8% | +$220K | 0.33% | 93 |
|
|
2021
Q3 | $2.66M | Sell |
380,736
-2,447
| -0.6% | -$17.1K | 0.33% | 95 |
|
|
2021
Q2 | $3.19M | Buy |
383,183
+82,667
| +28% | +$689K | 0.37% | 91 |
|
|
2021
Q1 | $1.64M | Sell |
300,516
-31,599
| -10% | -$173K | 0.2% | 172 |
|
|
2020
Q4 | $1.43M | Sell |
332,115
-62,374
| -16% | -$268K | 0.18% | 181 |
|
|
2020
Q3 | $1.19M | Buy |
394,489
+145,653
| +59% | +$438K | 0.17% | 189 |
|
|
2020
Q2 | $771K | Sell |
248,836
-1,164
| -0.5% | -$3.61K | 0.13% | 217 |
|
|
2020
Q1 | $553K | Sell |
250,000
-274,264
| -52% | -$607K | 0.11% | 210 |
|
|
2019
Q4 | $1.6M | Buy |
524,264
+24,648
| +5% | +$75.2K | 0.2% | 173 |
|
|
2019
Q3 | $1.54M | Sell |
499,616
-57,270
| -10% | -$176K | 0.22% | 148 |
|
|
2019
Q2 | $1.11M | Buy |
556,886
+80,593
| +17% | +$161K | 0.15% | 208 |
|
|
2019
Q1 | $2.05M | Sell |
476,293
-13,146
| -3% | -$56.7K | 0.3% | 97 |
|
|
2018
Q4 | $1.56M | Sell |
489,439
-32,435
| -6% | -$103K | 0.24% | 129 |
|
|
2018
Q3 | $2.74M | Buy |
521,874
+21,330
| +4% | +$112K | 0.32% | 88 |
|
|
2018
Q2 | $2.68M | Buy |
500,544
+610
| +0.1% | +$3.26K | 0.34% | 90 |
|
|
2018
Q1 | $2.5M | Sell |
499,934
-36,747
| -7% | -$184K | 0.33% | 91 |
|
|
2017
Q4 | $1.77M | Sell |
536,681
-4,138
| -0.8% | -$13.7K | 0.23% | 131 |
|
|
2017
Q3 | $2.03M | Buy |
540,819
+111,359
| +26% | +$418K | 0.28% | 117 |
|
|
2017
Q2 | $1.1M | Buy |
429,460
+119,878
| +39% | +$306K | 0.16% | 186 |
|
|
2017
Q1 | $805K | Buy |
309,582
+71,052
| +30% | +$185K | 0.13% | 215 |
|
|
2016
Q4 | $728K | Buy |
238,530
+80,018
| +50% | +$244K | 0.12% | 201 |
|
|
2016
Q3 | $431K | Sell |
158,512
-3,696
| -2% | -$10.1K | 0.07% | 269 |
|
|
2016
Q2 | $464K | Sell |
162,208
-1,787
| -1% | -$5.11K | 0.08% | 245 |
|
|
2016
Q1 | $495K | Sell |
163,995
-21,613
| -12% | -$65.2K | 0.08% | 229 |
|
|
2015
Q4 | $644K | Sell |
185,608
-12,402
| -6% | -$43K | 0.1% | 210 |
|
|
2015
Q3 | $748K | Buy |
+198,010
| New | +$748K | 0.12% | 173 |
|